The MMTC press release did not state that the joint effort with the university was a Phase 1 clinical trial. Here is the lead statement for the press release - Micro Imaging Technology Enters Phase 1 of Its Collaboration With Northern Michigan University.
Information regarding clinical trials testing as established by the Federal Drug Administration can be found at the following URL.
The collaboration does not involve drug testing. Upon obtain staphylococcus identifiers, it is my understanding that the company will work with the AOAC Research Institute to validate the identification process.